Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-267 + pegIFN/RBV in Genotype 1 Chronic HCV
NCT01314261Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Mar 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ombitasvir in hepatitis C (HCV), sponsored by AbbVie Inc.. Started Mar 2011; status: completed.
02
Drugs
ombitasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01314261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01314261.